Global Immune Adjuvant Market Insights, Forecast to 2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

The global Immune Adjuvant market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Immune Adjuvant is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Immune Adjuvant is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Immune Adjuvant is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Immune Adjuvant include SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:
This report presents an overview of global market for Immune Adjuvant, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Immune Adjuvant, also provides the sales of main regions and countries.  of the upcoming market potential for Immune Adjuvant, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immune Adjuvant sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Immune Adjuvant market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Immune Adjuvant sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Immune Adjuvant in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Immune Adjuvant manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune Adjuvant sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

 1 Study Coverage
    1.1 Immune Adjuvant Product Introduction
    1.2 Market by Type
        1.2.1 Global Immune Adjuvant Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Freund's Adjuvant
        1.2.3 Cytokine Adjuvants
    1.3 Market by Application
        1.3.1 Global Immune Adjuvant Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Research
        1.3.3 Commercial
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Executive Summary
    2.1 Global Immune Adjuvant Sales Estimates and Forecasts 2019-2030
    2.2 Global Immune Adjuvant Revenue by Region
        2.2.1 Global Immune Adjuvant Revenue by Region: 2019 VS 2023 VS 2030
        2.2.2 Global Immune Adjuvant Revenue by Region (2019-2024)
        2.2.3 Global Immune Adjuvant Revenue by Region (2025-2030)
        2.2.4 Global Immune Adjuvant Revenue Market Share by Region (2019-2030)
    2.3 Global Immune Adjuvant Sales Estimates and Forecasts 2019-2030
    2.4 Global Immune Adjuvant Sales by Region
        2.4.1 Global Immune Adjuvant Sales by Region: 2019 VS 2023 VS 2030
        2.4.2 Global Immune Adjuvant Sales by Region (2019-2024)
        2.4.3 Global Immune Adjuvant Sales by Region (2025-2030)
        2.4.4 Global Immune Adjuvant Sales Market Share by Region (2019-2030)
    2.5 US & Canada
    2.6 Europe
    2.7 China
    2.8 Asia (excluding China)
    2.9 Middle East, Africa and Latin America

 3 Competition by Manufactures
    3.1 Global Immune Adjuvant Sales by Manufacturers
        3.1.1 Global Immune Adjuvant Sales by Manufacturers (2019-2024)
        3.1.2 Global Immune Adjuvant Sales Market Share by Manufacturers (2019-2024)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immune Adjuvant in 2023
    3.2 Global Immune Adjuvant Revenue by Manufacturers
        3.2.1 Global Immune Adjuvant Revenue by Manufacturers (2019-2024)
        3.2.2 Global Immune Adjuvant Revenue Market Share by Manufacturers (2019-2024)
        3.2.3 Global Top 10 and Top 5 Companies by Immune Adjuvant Revenue in 2023
    3.3 Global Key Players of Immune Adjuvant, Industry Ranking, 2022 VS 2023 VS 2024
    3.4 Global Immune Adjuvant Sales Price by Manufacturers
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Immune Adjuvant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Immune Adjuvant, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Immune Adjuvant, Product Offered and Application
    3.8 Global Key Manufacturers of Immune Adjuvant, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans

 4 Market Size by Type
    4.1 Global Immune Adjuvant Sales by Type
        4.1.1 Global Immune Adjuvant Historical Sales by Type (2019-2024)
        4.1.2 Global Immune Adjuvant Forecasted Sales by Type (2025-2030)
        4.1.3 Global Immune Adjuvant Sales Market Share by Type (2019-2030)
    4.2 Global Immune Adjuvant Revenue by Type
        4.2.1 Global Immune Adjuvant Historical Revenue by Type (2019-2024)
        4.2.2 Global Immune Adjuvant Forecasted Revenue by Type (2025-2030)
        4.2.3 Global Immune Adjuvant Revenue Market Share by Type (2019-2030)
    4.3 Global Immune Adjuvant Price by Type
        4.3.1 Global Immune Adjuvant Price by Type (2019-2024)
        4.3.2 Global Immune Adjuvant Price Forecast by Type (2025-2030)

 5 Market Size by Application
    5.1 Global Immune Adjuvant Sales by Application
        5.1.1 Global Immune Adjuvant Historical Sales by Application (2019-2024)
        5.1.2 Global Immune Adjuvant Forecasted Sales by Application (2025-2030)
        5.1.3 Global Immune Adjuvant Sales Market Share by Application (2019-2030)
    5.2 Global Immune Adjuvant Revenue by Application
        5.2.1 Global Immune Adjuvant Historical Revenue by Application (2019-2024)
        5.2.2 Global Immune Adjuvant Forecasted Revenue by Application (2025-2030)
        5.2.3 Global Immune Adjuvant Revenue Market Share by Application (2019-2030)
    5.3 Global Immune Adjuvant Price by Application
        5.3.1 Global Immune Adjuvant Price by Application (2019-2024)
        5.3.2 Global Immune Adjuvant Price Forecast by Application (2025-2030)

 6 US & Canada
    6.1 US & Canada Immune Adjuvant Market Size by Type
        6.1.1 US & Canada Immune Adjuvant Sales by Type (2019-2030)
        6.1.2 US & Canada Immune Adjuvant Revenue by Type (2019-2030)
    6.2 US & Canada Immune Adjuvant Market Size by Application
        6.2.1 US & Canada Immune Adjuvant Sales by Application (2019-2030)
        6.2.2 US & Canada Immune Adjuvant Revenue by Application (2019-2030)
    6.3 US & Canada Immune Adjuvant Market Size by Country
        6.3.1 US & Canada Immune Adjuvant Revenue by Country: 2019 VS 2023 VS 2030
        6.3.2 US & Canada Immune Adjuvant Sales by Country (2019-2030)
        6.3.3 US & Canada Immune Adjuvant Revenue by Country (2019-2030)
        6.3.4 US
        6.3.5 Canada

 7 Europe
    7.1 Europe Immune Adjuvant Market Size by Type
        7.1.1 Europe Immune Adjuvant Sales by Type (2019-2030)
        7.1.2 Europe Immune Adjuvant Revenue by Type (2019-2030)
    7.2 Europe Immune Adjuvant Market Size by Application
        7.2.1 Europe Immune Adjuvant Sales by Application (2019-2030)
        7.2.2 Europe Immune Adjuvant Revenue by Application (2019-2030)
    7.3 Europe Immune Adjuvant Market Size by Country
        7.3.1 Europe Immune Adjuvant Revenue by Country: 2019 VS 2023 VS 2030
        7.3.2 Europe Immune Adjuvant Sales by Country (2019-2030)
        7.3.3 Europe Immune Adjuvant Revenue by Country (2019-2030)
        7.3.4 Germany
        7.3.5 France
        7.3.6 U.K.
        7.3.7 Italy
        7.3.8 Russia

 8 China
    8.1 China Immune Adjuvant Market Size
        8.1.1 China Immune Adjuvant Sales  (2019-2030)
        8.1.2 China Immune Adjuvant Revenue  (2019-2030)
    8.2 China Immune Adjuvant Market Size by Application
        8.2.1 China Immune Adjuvant Sales by Application (2019-2030)
        8.2.2 China Immune Adjuvant Revenue by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Immune Adjuvant Market Size by Type
        9.1.1 Asia Immune Adjuvant Sales by Type (2019-2030)
        9.1.2 Asia Immune Adjuvant Revenue by Type (2019-2030)
    9.2 Asia Immune Adjuvant Market Size by Application
        9.2.1 Asia Immune Adjuvant Sales by Application (2019-2030)
        9.2.2 Asia Immune Adjuvant Revenue by Application (2019-2030)
    9.3 Asia Immune Adjuvant Sales by Region
        9.3.1 Asia Immune Adjuvant Revenue by Region: 2019 VS 2023 VS 2030
        9.3.2 Asia Immune Adjuvant Revenue by Region (2019-2030)
        9.3.3 Asia Immune Adjuvant Sales by Region (2019-2030)
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 China Taiwan
        9.3.7 Southeast Asia
        9.3.8 India

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Immune Adjuvant Market Size by Type
        10.1.1 Middle East, Africa and Latin America Immune Adjuvant Sales by Type (2019-2030)
        10.1.2 Middle East, Africa and Latin America Immune Adjuvant Revenue by Type (2019-2030)
    10.2 Middle East, Africa and Latin America Immune Adjuvant Market Size by Application
        10.2.1 Middle East, Africa and Latin America Immune Adjuvant Sales by Application (2019-2030)
        10.2.2 Middle East, Africa and Latin America Immune Adjuvant Revenue by Application (2019-2030)
    10.3 Middle East, Africa and Latin America Immune Adjuvant Sales by Country
        10.3.1 Middle East, Africa and Latin America Immune Adjuvant Revenue by Country: 2019 VS 2023 VS 2030
        10.3.2 Middle East, Africa and Latin America Immune Adjuvant Revenue by Country (2019-2030)
        10.3.3 Middle East, Africa and Latin America Immune Adjuvant Sales by Country (2019-2030)
        10.3.4 Brazil
        10.3.5 Mexico
        10.3.6 Turkey
        10.3.7 Israel
        10.3.8 GCC Countries

 11 Company Profiles
    11.1 SEPPIC
        11.1.1 SEPPIC Company Information
        11.1.2 SEPPIC Overview
        11.1.3 SEPPIC Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.1.4 SEPPIC Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 SEPPIC Recent Developments
    11.2 SDA BIO
        11.2.1 SDA BIO Company Information
        11.2.2 SDA BIO Overview
        11.2.3 SDA BIO Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.2.4 SDA BIO Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 SDA BIO Recent Developments
    11.3 Croda International Plc
        11.3.1 Croda International Plc Company Information
        11.3.2 Croda International Plc Overview
        11.3.3 Croda International Plc Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.3.4 Croda International Plc Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Croda International Plc Recent Developments
    11.4 SPI Pharma
        11.4.1 SPI Pharma Company Information
        11.4.2 SPI Pharma Overview
        11.4.3 SPI Pharma Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.4.4 SPI Pharma Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 SPI Pharma Recent Developments
    11.5 Phibro Animal Health Corporation
        11.5.1 Phibro Animal Health Corporation Company Information
        11.5.2 Phibro Animal Health Corporation Overview
        11.5.3 Phibro Animal Health Corporation Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.5.4 Phibro Animal Health Corporation Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Phibro Animal Health Corporation Recent Developments
    11.6 Tj Kaiwei
        11.6.1 Tj Kaiwei Company Information
        11.6.2 Tj Kaiwei Overview
        11.6.3 Tj Kaiwei Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.6.4 Tj Kaiwei Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Tj Kaiwei Recent Developments
    11.7 Novavax
        11.7.1 Novavax Company Information
        11.7.2 Novavax Overview
        11.7.3 Novavax Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.7.4 Novavax Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Novavax Recent Developments
    11.8 Zhuoyue
        11.8.1 Zhuoyue Company Information
        11.8.2 Zhuoyue Overview
        11.8.3 Zhuoyue Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.8.4 Zhuoyue Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Zhuoyue Recent Developments
    11.9 Aphios
        11.9.1 Aphios Company Information
        11.9.2 Aphios Overview
        11.9.3 Aphios Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.9.4 Aphios Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Aphios Recent Developments
    11.10 GSK
        11.10.1 GSK Company Information
        11.10.2 GSK Overview
        11.10.3 GSK Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.10.4 GSK Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 GSK Recent Developments
    11.11 CSL Limited
        11.11.1 CSL Limited Company Information
        11.11.2 CSL Limited Overview
        11.11.3 CSL Limited Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.11.4 CSL Limited Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 CSL Limited Recent Developments
    11.12 Brenntag Biosector
        11.12.1 Brenntag Biosector Company Information
        11.12.2 Brenntag Biosector Overview
        11.12.3 Brenntag Biosector Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.12.4 Brenntag Biosector Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Brenntag Biosector Recent Developments
    11.13 Abace
        11.13.1 Abace Company Information
        11.13.2 Abace Overview
        11.13.3 Abace Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.13.4 Abace Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Abace Recent Developments
    11.14 Avanti Polar Lipids
        11.14.1 Avanti Polar Lipids Company Information
        11.14.2 Avanti Polar Lipids Overview
        11.14.3 Avanti Polar Lipids Immune Adjuvant Sales, Price, Revenue and Gross Margin (2019-2024)
        11.14.4 Avanti Polar Lipids Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Avanti Polar Lipids Recent Developments

 12 Industry Chain and Sales Channels Analysis
    12.1 Immune Adjuvant Industry Chain Analysis
    12.2 Immune Adjuvant Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Immune Adjuvant Production Mode & Process
    12.4 Immune Adjuvant Sales and Marketing
        12.4.1 Immune Adjuvant Sales Channels
        12.4.2 Immune Adjuvant Distributors
    12.5 Immune Adjuvant Customers

 13 Market Dynamics
    13.1 Immune Adjuvant Industry Trends
    13.2 Immune Adjuvant Market Drivers
    13.3 Immune Adjuvant Market Challenges
    13.4 Immune Adjuvant Market Restraints

 14 Key Findings in The Global Immune Adjuvant Study

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Immune Adjuvant Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Freund's Adjuvant
    Table 3. Major Manufacturers of Cytokine Adjuvants
    Table 4. Global Immune Adjuvant Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Immune Adjuvant Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Immune Adjuvant Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Immune Adjuvant Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Immune Adjuvant Revenue Market Share by Region (2019-2024)
    Table 9. Global Immune Adjuvant Revenue Market Share by Region (2025-2030)
    Table 10. Global Immune Adjuvant Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Immune Adjuvant Sales by Region (2019-2024) & (KG)
    Table 12. Global Immune Adjuvant Sales by Region (2025-2030) & (KG)
    Table 13. Global Immune Adjuvant Sales Market Share by Region (2019-2024)
    Table 14. Global Immune Adjuvant Sales Market Share by Region (2025-2030)
    Table 15. Global Immune Adjuvant Sales by Manufacturers (2019-2024) & (KG)
    Table 16. Global Immune Adjuvant Sales Share by Manufacturers (2019-2024)
    Table 17. Global Immune Adjuvant Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Immune Adjuvant Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Immune Adjuvant, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Immune Adjuvant Price by Manufacturers 2019-2024 (US$/KG)
    Table 21. Global Immune Adjuvant Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Immune Adjuvant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Adjuvant as of 2023)
    Table 23. Global Key Manufacturers of Immune Adjuvant, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Immune Adjuvant, Product Offered and Application
    Table 25. Global Key Manufacturers of Immune Adjuvant, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Immune Adjuvant Sales by Type (2019-2024) & (KG)
    Table 28. Global Immune Adjuvant Sales by Type (2025-2030) & (KG)
    Table 29. Global Immune Adjuvant Sales Share by Type (2019-2024)
    Table 30. Global Immune Adjuvant Sales Share by Type (2025-2030)
    Table 31. Global Immune Adjuvant Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Immune Adjuvant Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Immune Adjuvant Revenue Share by Type (2019-2024)
    Table 34. Global Immune Adjuvant Revenue Share by Type (2025-2030)
    Table 35. Immune Adjuvant Price by Type (2019-2024) & (US$/KG)
    Table 36. Global Immune Adjuvant Price Forecast by Type (2025-2030) & (US$/KG)
    Table 37. Global Immune Adjuvant Sales by Application (2019-2024) & (KG)
    Table 38. Global Immune Adjuvant Sales by Application (2025-2030) & (KG)
    Table 39. Global Immune Adjuvant Sales Share by Application (2019-2024)
    Table 40. Global Immune Adjuvant Sales Share by Application (2025-2030)
    Table 41. Global Immune Adjuvant Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Immune Adjuvant Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Immune Adjuvant Revenue Share by Application (2019-2024)
    Table 44. Global Immune Adjuvant Revenue Share by Application (2025-2030)
    Table 45. Immune Adjuvant Price by Application (2019-2024) & (US$/KG)
    Table 46. Global Immune Adjuvant Price Forecast by Application (2025-2030) & (US$/KG)
    Table 47. US & Canada Immune Adjuvant Sales by Type (2019-2024) & (KG)
    Table 48. US & Canada Immune Adjuvant Sales by Type (2025-2030) & (KG)
    Table 49. US & Canada Immune Adjuvant Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Immune Adjuvant Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Immune Adjuvant Sales by Application (2019-2024) & (KG)
    Table 52. US & Canada Immune Adjuvant Sales by Application (2025-2030) & (KG)
    Table 53. US & Canada Immune Adjuvant Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Immune Adjuvant Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Immune Adjuvant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Immune Adjuvant Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Immune Adjuvant Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Immune Adjuvant Sales by Country (2019-2024) & (KG)
    Table 59. US & Canada Immune Adjuvant Sales by Country (2025-2030) & (KG)
    Table 60. Europe Immune Adjuvant Sales by Type (2019-2024) & (KG)
    Table 61. Europe Immune Adjuvant Sales by Type (2025-2030) & (KG)
    Table 62. Europe Immune Adjuvant Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Immune Adjuvant Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Immune Adjuvant Sales by Application (2019-2024) & (KG)
    Table 65. Europe Immune Adjuvant Sales by Application (2025-2030) & (KG)
    Table 66. Europe Immune Adjuvant Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Immune Adjuvant Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Immune Adjuvant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Immune Adjuvant Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Immune Adjuvant Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Immune Adjuvant Sales by Country (2019-2024) & (KG)
    Table 72. Europe Immune Adjuvant Sales by Country (2025-2030) & (KG)
    Table 73. China Immune Adjuvant Sales by Type (2019-2024) & (KG)
    Table 74. China Immune Adjuvant Sales by Type (2025-2030) & (KG)
    Table 75. China Immune Adjuvant Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Immune Adjuvant Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Immune Adjuvant Sales by Application (2019-2024) & (KG)
    Table 78. China Immune Adjuvant Sales by Application (2025-2030) & (KG)
    Table 79. China Immune Adjuvant Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Immune Adjuvant Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Immune Adjuvant Sales by Type (2019-2024) & (KG)
    Table 82. Asia Immune Adjuvant Sales by Type (2025-2030) & (KG)
    Table 83. Asia Immune Adjuvant Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Immune Adjuvant Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Immune Adjuvant Sales by Application (2019-2024) & (KG)
    Table 86. Asia Immune Adjuvant Sales by Application (2025-2030) & (KG)
    Table 87. Asia Immune Adjuvant Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Immune Adjuvant Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Immune Adjuvant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Immune Adjuvant Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Immune Adjuvant Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Immune Adjuvant Sales by Region (2019-2024) & (KG)
    Table 93. Asia Immune Adjuvant Sales by Region (2025-2030) & (KG)
    Table 94. Middle East, Africa and Latin America Immune Adjuvant Sales by Type (2019-2024) & (KG)
    Table 95. Middle East, Africa and Latin America Immune Adjuvant Sales by Type (2025-2030) & (KG)
    Table 96. Middle East, Africa and Latin America Immune Adjuvant Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Immune Adjuvant Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Immune Adjuvant Sales by Application (2019-2024) & (KG)
    Table 99. Middle East, Africa and Latin America Immune Adjuvant Sales by Application (2025-2030) & (KG)
    Table 100. Middle East, Africa and Latin America Immune Adjuvant Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Immune Adjuvant Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Immune Adjuvant Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Immune Adjuvant Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Immune Adjuvant Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Immune Adjuvant Sales by Country (2019-2024) & (KG)
    Table 106. Middle East, Africa and Latin America Immune Adjuvant Sales by Country (2025-2030) & (KG)
    Table 107. SEPPIC Company Information
    Table 108. SEPPIC Description and Major Businesses
    Table 109. SEPPIC Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 110. SEPPIC Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. SEPPIC Recent Developments
    Table 112. SDA BIO Company Information
    Table 113. SDA BIO Description and Major Businesses
    Table 114. SDA BIO Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 115. SDA BIO Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. SDA BIO Recent Developments
    Table 117. Croda International Plc Company Information
    Table 118. Croda International Plc Description and Major Businesses
    Table 119. Croda International Plc Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 120. Croda International Plc Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Croda International Plc Recent Developments
    Table 122. SPI Pharma Company Information
    Table 123. SPI Pharma Description and Major Businesses
    Table 124. SPI Pharma Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 125. SPI Pharma Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. SPI Pharma Recent Developments
    Table 127. Phibro Animal Health Corporation Company Information
    Table 128. Phibro Animal Health Corporation Description and Major Businesses
    Table 129. Phibro Animal Health Corporation Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 130. Phibro Animal Health Corporation Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Phibro Animal Health Corporation Recent Developments
    Table 132. Tj Kaiwei Company Information
    Table 133. Tj Kaiwei Description and Major Businesses
    Table 134. Tj Kaiwei Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 135. Tj Kaiwei Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Tj Kaiwei Recent Developments
    Table 137. Novavax Company Information
    Table 138. Novavax Description and Major Businesses
    Table 139. Novavax Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 140. Novavax Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Novavax Recent Developments
    Table 142. Zhuoyue Company Information
    Table 143. Zhuoyue Description and Major Businesses
    Table 144. Zhuoyue Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 145. Zhuoyue Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Zhuoyue Recent Developments
    Table 147. Aphios Company Information
    Table 148. Aphios Description and Major Businesses
    Table 149. Aphios Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 150. Aphios Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Aphios Recent Developments
    Table 152. GSK Company Information
    Table 153. GSK Description and Major Businesses
    Table 154. GSK Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 155. GSK Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. GSK Recent Developments
    Table 157. CSL Limited Company Information
    Table 158. CSL Limited Description and Major Businesses
    Table 159. CSL Limited Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 160. CSL Limited Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. CSL Limited Recent Developments
    Table 162. Brenntag Biosector Company Information
    Table 163. Brenntag Biosector Description and Major Businesses
    Table 164. Brenntag Biosector Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 165. Brenntag Biosector Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Brenntag Biosector Recent Developments
    Table 167. Abace Company Information
    Table 168. Abace Description and Major Businesses
    Table 169. Abace Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 170. Abace Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Abace Recent Developments
    Table 172. Avanti Polar Lipids Company Information
    Table 173. Avanti Polar Lipids Description and Major Businesses
    Table 174. Avanti Polar Lipids Immune Adjuvant Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
    Table 175. Avanti Polar Lipids Immune Adjuvant Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Avanti Polar Lipids Recent Developments
    Table 177. Key Raw Materials Lists
    Table 178. Raw Materials Key Suppliers Lists
    Table 179. Immune Adjuvant Distributors List
    Table 180. Immune Adjuvant Customers List
    Table 181. Immune Adjuvant Market Trends
    Table 182. Immune Adjuvant Market Drivers
    Table 183. Immune Adjuvant Market Challenges
    Table 184. Immune Adjuvant Market Restraints
    Table 185. Research Programs/Design for This Report
    Table 186. Key Data Information from Secondary Sources
    Table 187. Key Data Information from Primary Sources
List of Figures
    Figure 1. Immune Adjuvant Product Picture
    Figure 2. Global Immune Adjuvant Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Immune Adjuvant Market Share by Type in 2023 & 2030
    Figure 4. Freund's Adjuvant Product Picture
    Figure 5. Cytokine Adjuvants Product Picture
    Figure 6. Global Immune Adjuvant Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Immune Adjuvant Market Share by Application in 2023 & 2030
    Figure 8. Research
    Figure 9. Commercial
    Figure 10. Immune Adjuvant Report Years Considered
    Figure 11. Global Immune Adjuvant Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Immune Adjuvant Revenue 2019-2030 (US$ Million)
    Figure 13. Global Immune Adjuvant Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Immune Adjuvant Revenue Market Share by Region (2019-2030)
    Figure 15. Global Immune Adjuvant Sales 2019-2030 ((KG)
    Figure 16. Global Immune Adjuvant Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Immune Adjuvant Sales YoY (2019-2030) & (KG)
    Figure 18. US & Canada Immune Adjuvant Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Immune Adjuvant Sales YoY (2019-2030) & (KG)
    Figure 20. Europe Immune Adjuvant Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Immune Adjuvant Sales YoY (2019-2030) & (KG)
    Figure 22. China Immune Adjuvant Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Immune Adjuvant Sales YoY (2019-2030) & (KG)
    Figure 24. Asia (excluding China) Immune Adjuvant Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Immune Adjuvant Sales YoY (2019-2030) & (KG)
    Figure 26. Middle East, Africa and Latin America Immune Adjuvant Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Immune Adjuvant Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Immune Adjuvant in the World: Market Share by Immune Adjuvant Revenue in 2023
    Figure 29. Global Immune Adjuvant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Immune Adjuvant Sales Market Share by Type (2019-2030)
    Figure 31. Global Immune Adjuvant Revenue Market Share by Type (2019-2030)
    Figure 32. Global Immune Adjuvant Sales Market Share by Application (2019-2030)
    Figure 33. Global Immune Adjuvant Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Immune Adjuvant Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Immune Adjuvant Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Immune Adjuvant Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Immune Adjuvant Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Immune Adjuvant Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Immune Adjuvant Sales Share by Country (2019-2030)
    Figure 40. U.S. Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Immune Adjuvant Sales Market Share by Type (2019-2030)
    Figure 43. Europe Immune Adjuvant Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Immune Adjuvant Sales Market Share by Application (2019-2030)
    Figure 45. Europe Immune Adjuvant Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Immune Adjuvant Revenue Share by Country (2019-2030)
    Figure 47. Europe Immune Adjuvant Sales Share by Country (2019-2030)
    Figure 48. Germany Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 49. France Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 53. China Immune Adjuvant Sales Market Share by Type (2019-2030)
    Figure 54. China Immune Adjuvant Revenue Market Share by Type (2019-2030)
    Figure 55. China Immune Adjuvant Sales Market Share by Application (2019-2030)
    Figure 56. China Immune Adjuvant Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Immune Adjuvant Sales Market Share by Type (2019-2030)
    Figure 58. Asia Immune Adjuvant Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Immune Adjuvant Sales Market Share by Application (2019-2030)
    Figure 60. Asia Immune Adjuvant Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Immune Adjuvant Revenue Share by Region (2019-2030)
    Figure 62. Asia Immune Adjuvant Sales Share by Region (2019-2030)
    Figure 63. Japan Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 67. India Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Immune Adjuvant Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Immune Adjuvant Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Immune Adjuvant Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Immune Adjuvant Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Immune Adjuvant Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Immune Adjuvant Sales Share by Country (2019-2030)
    Figure 74. Brazil Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Immune Adjuvant Revenue (2019-2030) & (US$ Million)
    Figure 79. Immune Adjuvant Value Chain
    Figure 80. Immune Adjuvant Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed

The global Immune Adjuvant market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Immune Adjuvant is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Immune Adjuvant is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Immune Adjuvant is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Immune Adjuvant include SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:
This report presents an overview of global market for Immune Adjuvant, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Immune Adjuvant, also provides the sales of main regions and countries.  of the upcoming market potential for Immune Adjuvant, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immune Adjuvant sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Immune Adjuvant market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Immune Adjuvant sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including SEPPIC, SDA BIO, Croda International Plc, SPI Pharma, Phibro Animal Health Corporation, Tj Kaiwei, Novavax, Zhuoyue and Aphios, etc.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Immune Adjuvant in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Immune Adjuvant manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune Adjuvant sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.